Furthermore, the loss of p16INK4A gene expression, mainly caused by frequent p16INK4A promoter methylation, is known to have a strong relationship with poor prognosis in ESCC patients [36]. Here, CDKN2A is linked to esophageal squamous cell carcinoma.